tiprankstipranks
Eupraxia Pharmaceuticals (TSE:EPRX)
TSX:EPRX
Canadian Market
EPRX
Eupraxia Pharmaceuticals
RESEARCH TOOLSreports

Eupraxia Pharmaceuticals (EPRX) Cash flow

63 Followers

Eupraxia Pharmaceuticals Cash Flow

TSE:EPRX's free cash flow for Q4 2025 was C$-10.08M. For the 2025 fiscal year, TSE:EPRX's free cash flow was decreased by C$447.42K and operating cash flow was C$-9.89M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Mar 24Dec 22Dec 21
Operating Cash Flow
C$ -29.05MC$ -29.99MC$ -27.92MC$ -18.78MC$ -14.64M
Investing Cash Flow
C$ -599.26KC$ -75.16KC$ -99.03KC$ 8.70MC$ -14.45M
Financing Cash Flow
C$ 77.39MC$ 45.78MC$ 27.84MC$ 13.52MC$ 49.92M
End Cash Position
C$ 80.42MC$ 33.10MC$ 19.34MC$ 24.74MC$ 20.89M
Free Cash Flow
C$ -29.65MC$ -30.10MC$ -28.02MC$ -19.08MC$ -15.07M
Currency in CAD

Eupraxia Pharmaceuticals Cash Flow